Proximal Convoluted Tubule
Carbonic Anhydrase InhibitorsThe PCT is where the nephron does its bulk work · 65-80% of filtered Na+, water, and bicarb get reabsorbed here. It's the Amazon warehouse of the kidney. Huge volume, not very selective.
The enzyme doing the heavy lifting is carbonic anhydraseCarbonic anhydrase converts CO2 + H2O ↔ H2CO3 ↔ H+ + HCO3-. In the PCT, this reaction lets the tubule reabsorb filtered bicarb by converting it to CO2 (which crosses membranes freely), then converting it back inside the cell. Block the enzyme → bicarb stays in the urine → metabolic acidosis.. Block it, and bicarb can't be reabsorbed. It stays in the tubule, drags Na+ and water with it.
Clinical uses: Glaucoma (decreases aqueous humor production), altitude sickness (forces bicarb diuresis → compensatory hyperventilation), pseudotumor cerebriIdiopathic intracranial hypertension. Acetazolamide decreases CSF production by the choroid plexus (which also uses carbonic anhydrase). Same enzyme, different address..
Side effects: Metabolic acidosis, hypokalemia (bicarb wasting drags K+ with it), calcium phosphate kidney stones (alkaline urine precipitates calcium phosphate instead of the usual calcium oxalate).
Thick Ascending Limb
Loop DiureticsThe TAL is the powerhouse of the nephron's concentrating ability. It reabsorbs ~25% of filtered Na+ via the Na-K-2Cl cotransporter (NKCC2)One Na+, one K+, two Cl- ions cross together from tubular lumen into the cell. This generates the medullary concentration gradient that lets the collecting duct concentrate urine with ADH. Block NKCC2 → lose the gradient → massive diuresis.. This is also where the kidney builds the medullary concentration gradient that lets you concentrate urine later.
Block NKCC2 and you lose the gradient entirely. That's why loop diuretics are the most powerful diuretics · they don't just block Na+ reabsorption, they destroy the kidney's ability to concentrate.
The electrolyte carnage:
| Lost | Why |
|---|---|
| Na+ | Direct · NKCC2 is blocked |
| K+ | More Na+ in distal tubule → more Na/K exchange → K+ wasting |
| Ca2+ | Paracellular Ca2+ reabsorption depends on the lumen-positive voltage from K+ recycling. Block NKCC2 → lose the voltage → Ca2+ stays in urine |
| Mg2+ | Same paracellular mechanism as calcium |
Clinical uses: Acute pulmonary edema (IV furosemide is first-line · works in minutes), CHF volume overload, hypercalcemia (loops waste calcium), acute kidney injury (maintain urine output).
Ethacrynic acid is the oddball · it's the only loop diuretic that is not a sulfonamide. Use it when the patient has a sulfa allergyFurosemide, bumetanide, and torsemide are all sulfonamide derivatives. Ethacrynic acid is a phenoxyacetic acid · structurally unrelated. Safe in sulfa allergy, but more ototoxic than the others.. Tradeoff: higher risk of ototoxicity.
Distal Convoluted Tubule
Thiazide DiureticsThe DCT reabsorbs only ~5% of filtered Na+ via the Na-Cl cotransporter (NCC)Simpler than NKCC2 · just Na+ and Cl-. No K+, no complex voltage games. Blocking NCC is a gentler diuresis than blocking NKCC2, which is why thiazides are maintenance drugs and loops are rescue drugs.. Less Na+ reabsorption means thiazides are weaker than loops. But they shine in chronic management.
The calcium twist: Thiazides increase calcium reabsorption in the DCT. Opposite of loops. Mechanism: blocking NCC → less intracellular Na+ → Na/Ca exchanger on basolateral side works harder → more Ca2+ pulled from tubule into blood.
Hypercalcemia → loop. Osteoporosis → thiazide. Kidney stones (calcium) → thiazide (less Ca2+ in urine = fewer stones).
Side effects (the HYPER-hypo pattern):
| Effect | Direction | Why It Matters |
|---|---|---|
| Hypokalemia | ↓ | Same mechanism as loops · more distal Na → more K wasting |
| Hyponatremia | ↓ | Thiazides are the #1 drug cause of hyponatremia in the elderly |
| Hypercalcemia | ↑ | Ca2+ reabsorption increased (the whole point sometimes) |
| Hyperglycemia | ↑ | K+ depletion impairs insulin release from beta cells |
| Hyperuricemia | ↑ | Competes with uric acid for secretion in PCT → gout flares |
| Hyperlipidemia | ↑ | Mild · LDL and TGs go up |
Collecting Duct
Potassium-Sparing DiureticsThe collecting duct is where aldosteroneAldosterone binds nuclear receptors in principal cells → upregulates ENaC (Na+ channels) on the luminal side and Na/K-ATPase on the basolateral side. Net effect: Na+ reabsorbed, K+ secreted. Block aldosterone → keep K+, lose Na+. does its final tuning · Na+ in, K+ out. This is where potassium-sparing diuretics live.
Two totally different mechanisms, same result:
| Trace It | Drugs | How |
|---|---|---|
| Aldosterone antagonists | Spironolactone, Eplerenone | Block the aldosterone receptor → no ENaC upregulation → Na+ stays in tubule, K+ stays in blood |
| ENaC blockers | Amiloride, Triamterene | Directly block the ENaC channelEpithelial sodium channel. The final gatekeeper for Na+ in the collecting duct. Even without aldosterone, some baseline ENaC activity exists. Amiloride plugs the channel directly. · don't need aldosterone to be involved |
Side effect: Gynecomastia (anti-androgen effect). Eplerenone is more selective → less gynecomastia but more expensive. 🔑 Spironolactone gives you spironol... man boobs. The "spiro" sounds like it's spinning your hormones. Eplerenone is the gentleman's version · same job, fewer side effects.
The danger: Hyperkalemia. These drugs SAVE potassium. Combine with an ACE inhibitor (which also raises K+) + renal insufficiency = cardiac arrest territory. Always check K+ levels.
Amiloride special use: Treats Liddle syndromeGain-of-function mutation in ENaC · the channel is always open, always reabsorbing Na+, always wasting K+. Looks like hyperaldosteronism but aldosterone is LOW. Amiloride plugs the overactive channel directly. Spironolactone won't work because the problem isn't aldosterone · it's the channel itself. (gain-of-function ENaC mutation). Also used to prevent lithium-induced nephrogenic DILithium enters principal cells through ENaC and downregulates aquaporin-2. Amiloride blocks ENaC → blocks lithium entry → protects the collecting duct's concentrating ability. · blocks lithium entry through ENaC.
Nephron Map
Click a SegmentTap any segment to see which drugs act there, how they work, and what they break.
The Full Picture
Side-by-Side| Class | Site | K+ | Ca2+ | Acid-Base | Power |
|---|---|---|---|---|---|
| CA Inhibitors Acetazolamide |
PCT | ↓ | , | Met. Acidosis | Weak |
| Loop Furosemide |
TAL | ↓ | ↓ (wastes) | Met. Alkalosis | Strongest |
| Thiazide HCTZ |
DCT | ↓ | ↑ (saves) | Met. Alkalosis | Moderate |
| K-Sparing Spironolactone |
CD | ↑ (saves) | , | Met. Acidosis | Weakest |
Which Diuretic? Decision Tree
A patient walks in. Pick the right diuretic.
Test Yourself
Board-Style VignettesFour patients just walked in. They all need a diuretic. Don't give them the wrong one.
Refresh to get different questions.